SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Qualcomm Incorporated (QCOM) -- Ignore unavailable to you. Want to Upgrade?


To: limtex who wrote (13591)8/12/1998 10:35:00 AM
From: tero kuittinen  Read Replies (2) | Respond to of 152472
 
I probably shouldn't rise to the bait, but what the hell. Yeah, Nokia makes up over 50% of the HEX trading volume and more than 25% of Finnish exports. But we do also have Kone, which is the world's third biggest maker of elevators and escalators - recently Kone announced the introduction of the world's first elevator model that does not need a maintenance room. This has positioned the company as a much hotter innovator than the American Otis which is the world number one currently. If you're looking for the next Nokia-like Finnish success story (and you probably aren't) this could be it.

Polar, the world's number one maker of electronic pulse-measuring devices (which are coming in vogue among Venice Beach health nuts... this is supposed to be a yardstick of what will sell in Peoria in 2001) is also Finnish. That's my number two tip as the next mini-Nokia, these gadgets are the size and shape of watches and very handy if you want to monitor your pulse when you are jogging.

Instrumentarium is the world's leading maker of intensive care monitoring equipment, they just bought an American company to complement their high-tech products with a cheaper, low-tech line of monitors that some cheapskate HMO's apparently prefer.

Elcoteq is one of the world's ten biggest electronic component contractors and growing at over 60% annual rate (this is where those Estonian factories come in). Orion is one of the world's first companies to bring to market a drug for Parkinson's disease and a hot take-over prospect for some American pharma giant. Raisio's price has zoomed by over 1'000% in two years as the company licensed Johnson & Johnson to sell their revolutionary fat-substitute in American market. It's extracted from pine-tree wood pulp, tastes like butter and lowers sharply your "bad" cholesterol. Look for it in American food stores by mid-1999.

These are good prospects, because they are undervalued and have low visibility in international markets. They are where Nokia was at in 1993: innovative and aggressive companies poised on verge of rapid growth and mostly overlooked by the rest of the world. I think Nokia could help them get closer attention in coming years.

Tero